Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs

US Patent 9326950 · Granted May 3, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide inhibition of CCR3-mediated diseases or conditions2021
Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial2019
Peptide inhibition of CCR3-mediated diseases or conditions2019
Peptide-based stat inhibitor2017
Peptide-based stat inhibitor2017
Peptide-based stat inhibitor2017
Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling2016
Lipopeptide inhibitors of RAS oncoproteins2016
Lipopeptide inhibitors of RAS oncoproteins2016
Antiproliferative factor and methods of use2015
Derivatives of APF and methods of use2015
Synthetic peptide inhibitors of Wnt pathway2015